Rene Bollier
Family Medicine · Kansas City, MONPI 1639174345
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 350 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations.
Across 350 payments — averaging $14.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$677
- AbbVie$636
- Pfizer$367
- Novo Nordisk$361
- Takeda Pharmaceuticals U.S.A., Inc.$347
- Amgen$302
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,899100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 50 | $677 |
| AbbVie(2 entities) | 49 | $636 |
| Pfizer | 33 | $367 |
| Novo Nordisk | 30 | $361 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $347 |
| Amgen(2 entities) | 21 | $302 |
| AstraZeneca | 18 | $296 |
| Boehringer Ingelheim | 15 | $238 |
| Amarin Pharma, Inc. | 12 | $180 |
| Biohaven Pharmaceuticals, Inc. | 10 | $167 |
| Currax Pharmaceuticals LLC | 12 | $163 |
| Merck | 12 | $160 |
| Daiichi Sankyo Inc. | 9 | $136 |
| Johnson & Johnson | 7 | $106 |
| Kowa Pharmaceuticals America, Inc. | 7 | $90 |
| Novartis | 6 | $90 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $84 |
| Eisai Inc. | 5 | $82 |
| Abbott | 4 | $61 |
| Astellas Pharma US Inc | 4 | $45 |
| Ironshore Pharmaceuticals Inc. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Bausch Health US, LLC | 2 | $26 |
| Nalpropion Pharmaceuticals LLC | 2 | $24 |
| Nevro Corp. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $20 |
| Grifols USA, LLC | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $15 |
| GSK | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Exeltis, USA Inc. | 1 | $12 |
How this compares
$4,907 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Kansas City
- Blair ThedingerKansas City$71K
- Jon MattsonKansas City$53K
- Meredith LevineKansas City$26K
- Kelly SandriKansas City$17K
- Michael SimanovskyKansas City$16K
- Teresa MarshallKansas City$16K
- Nora GomezKansas City$15K
- Julie AlvarezKansas City$15K
- Neal MooreKansas City$14K
- Stephen AdamsSpringfield$636K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.